EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Molecular Pharmaceutics


 

Status
active
Indexing
CAS, SCOPUS, EBSCOhost, Proquest, British Library, PubMed, CABI, Ovid, Web of Science, and SwetsWise.
Subject

Source type
Journal
Publisher
ISBN ISSN
1543-8384
E ISSN
1543-8392
First volume
1
Last volume
20+
Publish city
Washington
Homepage
Description

Molecular Pharmaceutics publishes original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:

  • Modelling and simulation to aid mechanistic insights into drug delivery
  • Molecular understanding of formulations
  • Formulation performance under physiological conditions
  • Materials science as it relates to drug, excipients and drug delivery system efficacy.
  • Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence

Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.












Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )